XML 40 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1
STOCKHOLDERS' EQUITY AND STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Sep. 29, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]
The value of restricted stock grants that vest based on market conditions is computed on the date of grant using the Monte Carlo model with the following assumptions:
 
For the period ended September 29, 2018
Performance price target
$
5.25

 
$
6.00

 
$
7.00

Expected volatility
48.3
%
 
48.3
%
 
48.3
%
Interest rate
1.97
%
 
1.97
%
 
1.97
%
Expected life (years)
3

 
3

 
3

Dividend yield
%
 
%
 
%
NonVested Restricted Common Stock
 
Shares
 
Weighted
Average
Grant
Fair
Value
Balance, December 30, 2017
2,629,274

 
$
3.31

Granted
1,549,000

 
2.25

Forfeited
(622,025
)
 
4.13

Vested
(80,000
)
 
3.64

Balance, September 29, 2018
3,476,249

 
$
2.69

Stock-Based Compensation Expense
The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the three and nine months ended September 29, 2018 and September 30, 2017 (no tax benefits were recognized):
 
Three Months Ended
 
Nine Months Ended
 
September 29, 2018
 
September 30, 2017
 
September 29, 2018
 
September 30, 2017
Cost of product revenues
$
52,368

 
$
142,604

 
$
318,519

 
$
405,778

Research and development
159,436

 
203,288

 
627,519

 
616,500

Selling, general and administrative
979,026

 
676,137

 
2,932,581

 
1,967,879

Total
$
1,190,830

 
$
1,022,029

 
$
3,878,619

 
$
2,990,157

Unr